Valeant Pharma (VRX) Adds to Early Gains

August 9, 2016 9:47 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Valeant Pharma (NYSE: VRX) adds to early gains following this mornings reports, which could be related to comments on call that it expects to remain in compliance with covenants. Shares up 13.6%



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Short Sales, Trader Talk

Add Your Comment